Sodium chloride

Generic Name: Sodium chloride

Brand Names: Amphenol-40, As 3, Bi-peglyte, Bicart, Bss, Bss Ophthalmic Solution, Cardioplegic, Citrasate, Clinimix E 2.75/5, Colyte, Corvatrol, Dextrose and Electrolyte No. 75, Dianeal, Dianeal Low Calcium 1.5, Dianeal Pd-2/1.5, Extraneal, Eye Stream, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Golytely, H.E.L.P.bicel, Hemosate Ultra, Hespan, Hizentra, Hyperlyte, Intersol, Isolyte S, Isolyte S pH 7.4, Isoplate, Lactate 1-2-3, Lactated Ringers, Menopur, Moviprep, Muro 128, Naturalyte, Normosol-M, Normosol-R, Nulytely, Nxstage Pureflow, P-Care M, P-Care MG, P-care, P-care X, Peglyte, Phoxillum, Physiolyte, Physioneal 40, Physiosol, Plasma-lyte, Plasma-lyte 148, Plasma-lyte 148 In 5 % Dextrose, Plasma-lyte R, Plasmalyte A, Plegisol, Plenvu, Prismasol, Procalamine 3, Ringers, Sag-M, Sclerodex, Suflave, Tis-U-sol

Drug Type: Small Molecule

Chemical Formula: ClNa

CAS Number: 7647-14-5

Unique Ingredient Identifier: 451W47IQ8X

Background: Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. Sodium chloride is the primary salt in seawater and in the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential...

Indication: This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.

Associated Conditions: Allergic Rhinitis (AR), Corneal Edema, Dehydration, Dehydration Hypertonic, Fluid Loss, Hemodilution, Hypokalemia, Hyponatremia, Hypotonic Dehydration, Hypovolaemia, Increase in Intracranial Pressure (ICP), Increased Intra Ocular Pressure (IOP), Inflammation of the Nasal Mucosa, Isotonic Dehydration, Metabolic Acidosis, Nasal Congestion, Nasal irritation, Oliguria caused by Acute Renal Failure (ARF), Potassium deficiency, Sinusitis, Skin Irritation, Sodium Depletion, Dryness of the nose, Hypochloremic state, Mild Metabolic acidosis, Mild, moderate Metabolic Acidosis

Associated Therapies: Electrolyte replacement, Fluid replacement therapy, Heart-Lung-Machine, Oral rehydration therapy, Parenteral Nutrition, Parenteral rehydration therapy, Peritoneal dialysis therapy, Plasma Volume Replacement, Regional Citrate Anticoagulation (RCA), Renal Replacement Therapies, Urine alkalinization therapy, Wound irrigation therapy, Ear wax removal, Fluid and electrolyte maintenance therapy, Increased renal excretion of toxic substances, Maintenance source of fluid and electrolytes, Parenteral drug administration, Reducing brain mass

Clinical Trials

Scalp Block: Hemodynamic Stability and Patient Comfort In Craniotomy Patients

Phase 1

Withdrawn

Conditions: Tumor, Brain
Anesthesia, Local

Interventions: Drug: Lidocaine
Drug: Sodium chloride
Drug: Bupivacaine

First Posted Date: 2017-06-06

Last Posted Date: 2020-10-22

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT03177252

Study to Determine if Pre- and Post- Operative TAP Catheters With Ropivacaine Versus Placebo Affects Anesthetic, Narcotic Dosing, and Pain Scores

Phase 2

Conditions: Pain, Postoperative
Anesthesia, Local
Delirium

Interventions: Drug: Ropivacaine HCL
Drug: sodium chloride

First Posted Date: 2017-05-11

Last Posted Date: 2021-05-27

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 80

Registration Number: NCT03149783

Locations: 🇺🇸
Denver Veterans Affairs Medical Center, Denver, Colorado, United States

Low vs. Very Low Dose of Prophylactic Tranexamic Acid for Bleeding Reduction During Rhinoplasty

Phase 4

Conditions: Bleeding Reduction

Interventions: Drug: Tranexamic Acid
Drug: Sodium Chloride

First Posted Date: 2017-03-06

Last Posted Date: 2017-08-30

Lead Sponsor: Bartłomiej Wódarski

Target Recruit Count: 50

Registration Number: NCT03070847

Locations: 🇵🇱
Samodzielny Publiczny Szpital Kliniczny im. prof. W. Orłowskiego w Warszawie, Warsaw, Mazowieckie, Poland

Impact of NaHCO3- on Exercise Hyperpnea

Early Phase 1

Completed

Conditions: Pulmonary Ventilation

Interventions: Drug: Sodium Bicarbonate
Drug: Sodium Chloride

First Posted Date: 2017-02-20

Last Posted Date: 2017-02-20

Lead Sponsor: McGill University

Target Recruit Count: 20

Registration Number: NCT03057535

Locations: 🇨🇦
McGill University, Department of Kinesiology & Physical Education, Clinical Exercise & Respiratory Physiology Laboratory, Montreal, Quebec, Canada